학술논문

Cholinergic receptor binding in unimpaired older adults, mild cognitive impairment, and Alzheimer’s disease dementia
Document Type
article
Source
Alzheimer's Research & Therapy. 14(1)
Subject
Biomedical and Clinical Sciences
Health Sciences
Brain Disorders
Dementia
Acquired Cognitive Impairment
Alzheimer's Disease
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Clinical Research
Behavioral and Social Science
Neurosciences
Neurodegenerative
Aging
Aetiology
2.1 Biological and endogenous factors
Neurological
Mental health
Aged
Alzheimer Disease
Cognition Disorders
Cognitive Dysfunction
Humans
Neuropsychological Tests
Positron-Emission Tomography
Cholinergic receptors
Mild cognitive impairment
Alzheimer's disease
Cognitive aging
Alzheimer’s disease
Medical and Health Sciences
Biomedical and clinical sciences
Health sciences
Language
Abstract
BackgroundCholinergic neurotransmitter system dysfunction contributes to cognitive impairment in Alzheimer's disease and other syndromes. However, the specific cholinergic mechanisms and brain structures involved, time course of alterations, and relationships with specific cognitive deficits are not well understood.MethodsThis study included 102 older adults: 42 cognitively unimpaired (CU), 28 with mild cognitive impairment (MCI), and 32 with Alzheimer's disease (AD) dementia. Each participant underwent a neuropsychological assessment. Regional brain α4β2 nicotinic cholinergic receptor binding (VT/fp) was measured using 2-[18F]fluoro-3-(2(S)azetidinylmethoxy)pyridine (2FA) and PET imaging. Voxel-wise analyses of group differences were performed. Relationships between receptor binding and cognition, age, and cholinesterase inhibitor medication use were assessed using binding values in six prespecified regions of interest.ResultsSPM analysis showed the group VT/fp binding differences in the bilateral entorhinal cortex, hippocampus, insula, anterior cingulate, thalamus, and basal ganglia (p